title: Treatment of antibody-mediated rejection after kidney transplantation.
authors.affiliation: Division of Nephrology and Hypertension, Allegheny General Hospital, Pittsburgh, Pennsylvania 15252, USA. ksureshk@wpahs.org
authors.forename: K K
authors.initials: KK
authors.lastname: Sureshkumar
authors.forename: I U
authors.initials: IU
authors.lastname: Oti
authors.forename: S C
authors.initials: SC
authors.lastname: Baroody
authors.forename: S M
authors.initials: SM
authors.lastname: Hussain
authors.forename: B J
authors.initials: BJ
authors.lastname: Carpenter
authors.forename: D D
authors.initials: DD
authors.lastname: Nghiem
authors.forename: R J
authors.initials: RJ
authors.lastname: Marcus
mesh_terms: D000328:Adult; D000906:Antibodies / Q000276:immunology*; D015703:Antigens, CD / Q000032:analysis; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D019013:CD40 Antigens / Q000032:analysis; D005260:Female; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D014184:Transplantation, Homologous / Q000276:immunology / Q000473:pathology
chemical_list: D000906:Antibodies; D015703:Antigens, CD; D000961:Antilymphocyte Serum; D019013:CD40 Antigens; D007166:Immunosuppressive Agents